Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

CLINICAL IMPACT BY 24 MONTHS ACCORDING TO BCR/ABL1 TRANSCRIPT LEVEL AT 3 AND 6 MONTHS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH RADOTINIB 300MG BID OR IMATINIB

Y. R. Do,J. Y. Kwak, H. Kim, J. A. Kim, H. J. Kim,J. S. Park, J. S. Chung,H. J. Shin, S. H. Kim,D. Y. Kim,U. Bunworasate,C. W. Choi, N. S. Comia,D. Y. Zang, S. J. Oh,S. Jootar,A. H. Reksodiputro, W. S. Lee,Y. C. Mun,J. H. Kong, P. B. Caguioa,J. Park,C. W. Jung,D. W. Kim

HAEMATOLOGICA（2018）

Cited 0|Views52
No score
Key words
chronic phase chronic myeloid,bcr/abl1 transcript level at,leukemia patients,radotinib 300mg bid
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined